相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin
David Dahlgren et al.
PHARMACEUTICS (2020)
Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches
D. J. Brayden et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat
David Dahlgren et al.
PHARMACEUTICS (2020)
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
Andy Chi-Lung Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides
Gang Yang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Quantifying the Value of Orally Delivered Biologic Therapies: A Cost-Effectiveness Analysis of Oral Semaglutide
Alex Abramson et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Intestinal absorption-modifying excipients: A current update on preclinical in vivo evaluations
D. Dahlgren et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model
D. Dahlgren et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions
C. Roos et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2
Isabel Lozoya-Agullo et al.
PHARMACEUTICAL RESEARCH (2018)
Cell-Cell Junctions Organize Structural and Signaling Networks
Miguel A. Garcia et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Jolene L. Lau et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs
D. Dahlgren et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway
Adi Schumacher-Klinger et al.
MOLECULAR PHARMACEUTICS (2018)
Time-dependent effects on small intestinal transport by absorption-modifying excipients
D. Dahlgren et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport
D. Dahlgren et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Oral peptide delivery: Translational challenges due to physiological effects
Puneet Tyagi et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
Stephen T. Buckley et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A Comprehensive Map of FDA-Approved Pharmaceutical Products
Hao Zhong et al.
PHARMACEUTICS (2018)
Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker 51Cr-EDTA
David Dahlgren et al.
MOLECULAR PHARMACEUTICS (2017)
Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment
Thomas C. Marbury et al.
CLINICAL PHARMACOKINETICS (2017)
Intestinal permeation enhancers for oral peptide delivery
Sam Maher et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Molecular simulation of nonfacilitated membrane permeation
Ernest Awoonor-Williams et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms
David Dahlgren et al.
MOLECULAR PHARMACEUTICS (2016)
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
Abdul Muheem et al.
SAUDI PHARMACEUTICAL JOURNAL (2016)
Stability of peptide drugs in the colon
Jie Wang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Rational design of agents to transiently increase paracellular permeability
Kinam Park
JOURNAL OF CONTROLLED RELEASE (2015)
Cell-Permeable Cyclic Peptides from Synthetic Libraries Inspired by Natural Products
William M. Hewitt et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Human in Vivo Regional Intestinal Permeability: Quantitation Using Site-Specific Drug Absorption Data
Erik Sjogren et al.
MOLECULAR PHARMACEUTICS (2015)
Toward Oral Delivery of Biopharmaceuticals: An Assessment of the Gastrointestinal Stability of 17 Peptide Drugs
Jie Wang et al.
MOLECULAR PHARMACEUTICS (2015)
The selective cyclooxygenase-2 inhibitor parecoxib markedly improves the ability of the duodenum to regulate luminal hypertonicity in anaesthetized rats
J. Sedin et al.
ACTA PHYSIOLOGICA (2012)
Desmopressin duration of antidiuretic action in patients with central diabetes insipidus
Kristian Vinter Juul et al.
ENDOCRINE (2011)
Comparative study of the effect of luminal hypotonicity on mucosal permeability in rat upper gastrointestinal tract
L. Pihl et al.
ACTA PHYSIOLOGICA (2008)
Modulation of mucosal permeability by vasoactive intestinal peptide or lidocaine affects the adjustment of luminal hypotonicity in rat duodenum
O. Nylander et al.
ACTA PHYSIOLOGICA (2007)
Luminal hypotonicity increases duodenal mucosal permeability by a mechanism involving 5-hydroxytryptamine
O Nylander et al.
ACTA PHYSIOLOGICA (2006)
Hypotonicity-induced increases in duodenal mucosal permeability facilitates adjustment of luminal osmolality
O Nylander et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Hexarelin -: evaluation of factors influencing oral bioavailability and ways to improve absorption
C Westberg et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2001)
Permeability of the rat small intestinal epithelium along the villus-crypt axis:: Effects of glucose transport
BM Fihn et al.
GASTROENTEROLOGY (2000)